BioTime, Inc. (BTX) Subsidiary Cell Cure Neurosciences Receives $1.5 Million Grant from Israeli Agency
BioTime is a biotechnology company focused on regenerative medicine and blood plasma volume expanders. The company's broad platform of stem cell technologies is enhanced through subsidiaries focused on specific fields of application. One such subsidiary is Cell Cure Neurosciences Ltd., which focuses on becoming a leading supplier of human cell-based therapies for the treatment of retinal and neural degenerative diseases. The company announced today that its Cell Cure Neurosciences subsidiary has been awarded a grant of approximately $1.5 million from Israel's Office of the Chief Scientist for 2013. The grant will help finance the development of OpRegen, a cell-based therapeutic…